nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.583	1	CiPCiCtD
Boceprevir—CYP3A5—Beclomethasone—psoriasis	0.0343	0.179	CbGbCtD
Boceprevir—CYP3A5—Mycophenolate mofetil—psoriasis	0.0137	0.0714	CbGbCtD
Boceprevir—CYP3A4—Calcitriol—psoriasis	0.0119	0.0623	CbGbCtD
Boceprevir—CYP3A5—Hydrocortisone—psoriasis	0.011	0.0573	CbGbCtD
Boceprevir—CYP3A5—Cyclosporine—psoriasis	0.0104	0.0541	CbGbCtD
Boceprevir—CYP3A4—Methoxsalen—psoriasis	0.00928	0.0484	CbGbCtD
Boceprevir—ABCB1—Mycophenolate mofetil—psoriasis	0.00889	0.0464	CbGbCtD
Boceprevir—CTSK—skeletal joint—psoriasis	0.00853	0.334	CbGeAlD
Boceprevir—ABCB1—Betamethasone—psoriasis	0.00763	0.0398	CbGbCtD
Boceprevir—ABCB1—Prednisolone—psoriasis	0.00753	0.0393	CbGbCtD
Boceprevir—ABCB1—Hydrocortisone—psoriasis	0.00714	0.0373	CbGbCtD
Boceprevir—ABCB1—Prednisone—psoriasis	0.00711	0.0371	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—psoriasis	0.00682	0.0356	CbGbCtD
Boceprevir—ABCB1—Cyclosporine—psoriasis	0.00674	0.0352	CbGbCtD
Boceprevir—CYP3A4—Cholecalciferol—psoriasis	0.00614	0.0321	CbGbCtD
Boceprevir—CTSS—synovial membrane of synovial joint—psoriasis	0.00568	0.222	CbGeAlD
Boceprevir—CYP3A4—Triamcinolone—psoriasis	0.00533	0.0278	CbGbCtD
Boceprevir—CYP3A4—Mycophenolate mofetil—psoriasis	0.00533	0.0278	CbGbCtD
Boceprevir—CYP3A4—Betamethasone—psoriasis	0.00457	0.0239	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—psoriasis	0.00451	0.0236	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—psoriasis	0.00444	0.0232	CbGbCtD
Boceprevir—CYP3A4—Hydrocortisone—psoriasis	0.00428	0.0223	CbGbCtD
Boceprevir—CYP3A4—Prednisone—psoriasis	0.00426	0.0222	CbGbCtD
Boceprevir—CYP3A4—Cyclosporine—psoriasis	0.00404	0.0211	CbGbCtD
Boceprevir—ABCB1—Methotrexate—psoriasis	0.00357	0.0186	CbGbCtD
Boceprevir—CYP3A4—Dexamethasone—psoriasis	0.00266	0.0139	CbGbCtD
Boceprevir—CTSV—skin of body—psoriasis	0.00209	0.0818	CbGeAlD
Boceprevir—CMA1—skin of body—psoriasis	0.002	0.0782	CbGeAlD
Boceprevir—CTSL—skin of body—psoriasis	0.00171	0.0669	CbGeAlD
Boceprevir—CTSL—tendon—psoriasis	0.0013	0.0509	CbGeAlD
Boceprevir—CTSK—skin of body—psoriasis	0.00129	0.0504	CbGeAlD
Boceprevir—CTSS—skin of body—psoriasis	0.00113	0.0441	CbGeAlD
Boceprevir—CTSK—tendon—psoriasis	0.00098	0.0383	CbGeAlD
Boceprevir—CTSS—tendon—psoriasis	0.000859	0.0336	CbGeAlD
Boceprevir—CTSL—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000282	0.103	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Fluocinonide—psoriasis	0.000226	0.0826	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Beclomethasone—psoriasis	0.000226	0.0826	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.00022	0.0802	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Clobetasol propionate—psoriasis	0.000143	0.0522	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Clobetasol propionate—psoriasis	0.000143	0.0522	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Beclomethasone—psoriasis	0.000115	0.0418	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Fluocinonide—psoriasis	0.000115	0.0418	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Beclomethasone—psoriasis	0.000115	0.0418	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluocinonide—psoriasis	0.000115	0.0418	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000111	0.0407	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000111	0.0407	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—psoriasis	0.000103	0.0376	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—psoriasis	0.000103	0.0376	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—psoriasis	0.000101	0.0368	CbGdCrCtD
Boceprevir—CTSK—Extracellular matrix organization—ICAM1—psoriasis	9.82e-05	0.00129	CbGpPWpGaD
Boceprevir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.8e-05	0.00129	CbGpPWpGaD
Boceprevir—CTSK—Immune System—DDX58—psoriasis	9.76e-05	0.00128	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TAGAP—psoriasis	9.71e-05	0.00127	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-A—psoriasis	9.57e-05	0.00126	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IFIH1—psoriasis	9.5e-05	0.00125	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	9.44e-05	0.00124	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—REL—psoriasis	9.4e-05	0.00123	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—SOCS1—psoriasis	9.15e-05	0.0012	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—SOCS1—psoriasis	9.15e-05	0.0012	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.14e-05	0.0012	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERAP1—psoriasis	9.13e-05	0.0012	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HLA-E—psoriasis	9.07e-05	0.00119	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-C—psoriasis	9e-05	0.00118	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ITGAL—psoriasis	8.93e-05	0.00117	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ITGAL—psoriasis	8.93e-05	0.00117	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TNFAIP3—psoriasis	8.89e-05	0.00117	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ACE—psoriasis	8.83e-05	0.00116	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—JUN—psoriasis	8.79e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SOCS1—psoriasis	8.78e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—SOCS1—psoriasis	8.78e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-E—psoriasis	8.71e-05	0.00114	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-C—psoriasis	8.65e-05	0.00113	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—NFKB1—psoriasis	8.46e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSV—Immune System—REL—psoriasis	8.35e-05	0.0011	CbGpPWpGaD
Boceprevir—CTSL—Immune System—REL—psoriasis	8.35e-05	0.0011	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFIH1—psoriasis	8.11e-05	0.00106	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFIH1—psoriasis	8.11e-05	0.00106	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ICAM1—psoriasis	8.09e-05	0.00106	CbGpPWpGaD
Boceprevir—CTSS—Immune System—DDX58—psoriasis	8.04e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HLA-B—psoriasis	7.8e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HLA-B—psoriasis	7.8e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—psoriasis	7.79e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD8A—psoriasis	7.79e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—psoriasis	7.78e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—psoriasis	7.78e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-C—psoriasis	7.69e-05	0.00101	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-C—psoriasis	7.69e-05	0.00101	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TNFAIP3—psoriasis	7.59e-05	0.000996	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TNFAIP3—psoriasis	7.59e-05	0.000996	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—SOCS1—psoriasis	7.58e-05	0.000994	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-B—psoriasis	7.49e-05	0.000983	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-B—psoriasis	7.49e-05	0.000983	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-E—psoriasis	7.47e-05	0.00098	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ITGAL—psoriasis	7.4e-05	0.00097	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.28e-05	0.000955	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SOCS1—psoriasis	7.28e-05	0.000954	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL13—psoriasis	7.24e-05	0.000949	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—psoriasis	7.23e-05	0.000948	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-E—psoriasis	7.18e-05	0.000941	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-A—psoriasis	6.94e-05	0.00091	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-A—psoriasis	6.94e-05	0.00091	CbGpPWpGaD
Boceprevir—CTSK—Immune System—REL—psoriasis	6.92e-05	0.000907	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CRP—psoriasis	6.9e-05	0.000904	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CRP—psoriasis	6.9e-05	0.000904	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFIH1—psoriasis	6.72e-05	0.000881	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL17A—psoriasis	6.66e-05	0.000873	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HLA-B—psoriasis	6.47e-05	0.000848	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD8A—psoriasis	6.45e-05	0.000846	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—psoriasis	6.45e-05	0.000845	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-E—psoriasis	6.38e-05	0.000836	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-E—psoriasis	6.38e-05	0.000836	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.37e-05	0.000835	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-C—psoriasis	6.37e-05	0.000835	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-DRB1—psoriasis	6.34e-05	0.000832	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-DRB1—psoriasis	6.34e-05	0.000832	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TNFAIP3—psoriasis	6.29e-05	0.000825	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NFKBIA—psoriasis	6.29e-05	0.000825	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NFKBIA—psoriasis	6.29e-05	0.000825	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—SOCS1—psoriasis	6.24e-05	0.000818	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-B—psoriasis	6.21e-05	0.000814	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL12B—psoriasis	6.19e-05	0.000812	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ITGAL—psoriasis	6.09e-05	0.000799	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ICAM1—psoriasis	6.09e-05	0.000798	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ICAM1—psoriasis	6.09e-05	0.000798	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-E—psoriasis	6.04e-05	0.000793	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NFKBIA—psoriasis	6.04e-05	0.000792	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NFKBIA—psoriasis	6.04e-05	0.000792	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—SOCS1—psoriasis	5.99e-05	0.000786	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL20—psoriasis	5.82e-05	0.000763	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-A—psoriasis	5.75e-05	0.000754	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—psoriasis	5.72e-05	0.000749	CbGpPWpGaD
Boceprevir—CTSS—Immune System—REL—psoriasis	5.7e-05	0.000747	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.63e-05	0.000738	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Hydrocortisone—psoriasis	5.63e-05	0.0205	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Hydrocortisone—psoriasis	5.63e-05	0.0205	CbGdCrCtD
Boceprevir—CTSS—Immune System—IFIH1—psoriasis	5.53e-05	0.000725	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—LEP—psoriasis	5.48e-05	0.000719	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SOCS1—psoriasis	5.33e-05	0.000699	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SOCS1—psoriasis	5.33e-05	0.000699	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-B—psoriasis	5.32e-05	0.000698	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—psoriasis	5.32e-05	0.000697	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—psoriasis	5.31e-05	0.000696	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-E—psoriasis	5.29e-05	0.000693	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.28e-05	0.000692	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-DRB1—psoriasis	5.26e-05	0.000689	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-C—psoriasis	5.24e-05	0.000688	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Betamethasone—psoriasis	5.23e-05	0.0191	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Dexamethasone—psoriasis	5.23e-05	0.0191	CbGdCrCtD
Boceprevir—CTSK—Innate Immune System—NFKBIA—psoriasis	5.21e-05	0.000683	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.21e-05	0.000683	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TNFAIP3—psoriasis	5.18e-05	0.000679	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TYK2—psoriasis	5.15e-05	0.000676	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TYK2—psoriasis	5.15e-05	0.000676	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-B—psoriasis	5.11e-05	0.00067	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—psoriasis	5.11e-05	0.0186	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Triamcinolone—psoriasis	5.11e-05	0.0186	CbGdCrCtD
Boceprevir—CTSK—Adaptive Immune System—ICAM1—psoriasis	5.04e-05	0.000662	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NFKBIA—psoriasis	5.01e-05	0.000656	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5e-05	0.000656	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Prednisone—psoriasis	4.85e-05	0.0177	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—psoriasis	4.85e-05	0.0177	CbGdCrCtD
Boceprevir—CTSS—Adaptive Immune System—HLA-A—psoriasis	4.74e-05	0.000621	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Prednisolone—psoriasis	4.73e-05	0.0173	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—psoriasis	4.73e-05	0.0173	CbGdCrCtD
Boceprevir—CTSV—Immune System—CD8A—psoriasis	4.72e-05	0.00062	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—psoriasis	4.72e-05	0.00062	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—psoriasis	4.71e-05	0.000617	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—psoriasis	4.66e-05	0.000611	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—psoriasis	4.66e-05	0.000611	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.55e-05	0.000597	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-B—psoriasis	4.55e-05	0.000596	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-B—psoriasis	4.55e-05	0.000596	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—psoriasis	4.53e-05	0.000594	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—psoriasis	4.47e-05	0.000587	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—psoriasis	4.47e-05	0.000587	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SOCS1—psoriasis	4.41e-05	0.000579	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL4—psoriasis	4.4e-05	0.000578	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-E—psoriasis	4.35e-05	0.000571	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-DRB1—psoriasis	4.33e-05	0.000568	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.31e-05	0.000565	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.3e-05	0.000564	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NFKBIA—psoriasis	4.29e-05	0.000563	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TYK2—psoriasis	4.27e-05	0.00056	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-A—psoriasis	4.21e-05	0.000552	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-A—psoriasis	4.21e-05	0.000552	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—JUN—psoriasis	4.17e-05	0.000547	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—JUN—psoriasis	4.17e-05	0.000547	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ICAM1—psoriasis	4.15e-05	0.000545	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NFKBIA—psoriasis	4.12e-05	0.00054	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—psoriasis	4.02e-05	0.000527	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—psoriasis	4.02e-05	0.000527	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NFKB1—psoriasis	4.01e-05	0.000526	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NFKB1—psoriasis	4.01e-05	0.000526	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.01e-05	0.000526	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.99e-05	0.000523	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.92e-05	0.000515	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD8A—psoriasis	3.92e-05	0.000513	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—psoriasis	3.86e-05	0.000506	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NFKB1—psoriasis	3.85e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NFKB1—psoriasis	3.85e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DRB1—psoriasis	3.85e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-DRB1—psoriasis	3.85e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-B—psoriasis	3.77e-05	0.000494	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD4—psoriasis	3.71e-05	0.000486	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ICAM1—psoriasis	3.69e-05	0.000484	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ICAM1—psoriasis	3.69e-05	0.000484	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKBIA—psoriasis	3.66e-05	0.00048	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NFKBIA—psoriasis	3.66e-05	0.00048	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.65e-05	0.000478	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—psoriasis	3.64e-05	0.000478	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SOCS1—psoriasis	3.64e-05	0.000477	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TYK2—psoriasis	3.52e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-A—psoriasis	3.49e-05	0.000458	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—JUN—psoriasis	3.46e-05	0.000453	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CRP—psoriasis	3.33e-05	0.000437	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NFKB1—psoriasis	3.33e-05	0.000436	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—psoriasis	3.22e-05	0.000423	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SOCS1—psoriasis	3.2e-05	0.00042	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NFKB1—psoriasis	3.19e-05	0.000419	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DRB1—psoriasis	3.19e-05	0.000418	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD4—psoriasis	3.18e-05	0.000417	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-B—psoriasis	3.1e-05	0.000407	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ICAM1—psoriasis	3.06e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—psoriasis	3.05e-05	0.0004	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKBIA—psoriasis	3.04e-05	0.000398	CbGpPWpGaD
Boceprevir—Hypertension—Betamethasone—psoriasis	3.03e-05	0.000251	CcSEcCtD
Boceprevir—Paraesthesia—Hydrocortisone—psoriasis	3.01e-05	0.000249	CcSEcCtD
Boceprevir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.01e-05	0.000249	CcSEcCtD
Boceprevir—CTSV—Immune System—TYK2—psoriasis	3e-05	0.000393	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TYK2—psoriasis	3e-05	0.000393	CbGpPWpGaD
Boceprevir—Urticaria—Cyclosporine—psoriasis	3e-05	0.000248	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—psoriasis	2.99e-05	0.000247	CcSEcCtD
Boceprevir—Myalgia—Dexamethasone—psoriasis	2.99e-05	0.000247	CcSEcCtD
Boceprevir—Body temperature increased—Cyclosporine—psoriasis	2.98e-05	0.000247	CcSEcCtD
Boceprevir—Abdominal pain—Cyclosporine—psoriasis	2.98e-05	0.000247	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—psoriasis	2.98e-05	0.000247	CcSEcCtD
Boceprevir—Anxiety—Betamethasone—psoriasis	2.98e-05	0.000247	CcSEcCtD
Boceprevir—Vomiting—Mycophenolic acid—psoriasis	2.97e-05	0.000246	CcSEcCtD
Boceprevir—Discomfort—Dexamethasone—psoriasis	2.95e-05	0.000244	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—psoriasis	2.95e-05	0.000244	CcSEcCtD
Boceprevir—Dyspepsia—Hydrocortisone—psoriasis	2.95e-05	0.000244	CcSEcCtD
Boceprevir—Rash—Mycophenolic acid—psoriasis	2.94e-05	0.000243	CcSEcCtD
Boceprevir—Dermatitis—Mycophenolic acid—psoriasis	2.94e-05	0.000243	CcSEcCtD
Boceprevir—Pain—Prednisolone—psoriasis	2.94e-05	0.000243	CcSEcCtD
Boceprevir—Urticaria—Mycophenolate mofetil—psoriasis	2.92e-05	0.000242	CcSEcCtD
Boceprevir—Headache—Mycophenolic acid—psoriasis	2.92e-05	0.000242	CcSEcCtD
Boceprevir—Decreased appetite—Hydrocortisone—psoriasis	2.92e-05	0.000241	CcSEcCtD
Boceprevir—Pharyngitis—Methotrexate—psoriasis	2.91e-05	0.000241	CcSEcCtD
Boceprevir—Body temperature increased—Mycophenolate mofetil—psoriasis	2.91e-05	0.000241	CcSEcCtD
Boceprevir—Abdominal pain—Mycophenolate mofetil—psoriasis	2.91e-05	0.000241	CcSEcCtD
Boceprevir—Urinary tract disorder—Methotrexate—psoriasis	2.9e-05	0.00024	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.9e-05	0.00024	CcSEcCtD
Boceprevir—Fatigue—Hydrocortisone—psoriasis	2.89e-05	0.000239	CcSEcCtD
Boceprevir—Vision blurred—Prednisone—psoriasis	2.88e-05	0.000239	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—psoriasis	2.88e-05	0.000238	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.88e-05	0.000238	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-A—psoriasis	2.87e-05	0.000377	CbGpPWpGaD
Boceprevir—Pain—Hydrocortisone—psoriasis	2.87e-05	0.000237	CcSEcCtD
Boceprevir—Insomnia—Triamcinolone—psoriasis	2.86e-05	0.000236	CcSEcCtD
Boceprevir—Infection—Betamethasone—psoriasis	2.85e-05	0.000236	CcSEcCtD
Boceprevir—Infection—Dexamethasone—psoriasis	2.85e-05	0.000236	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—JUN—psoriasis	2.85e-05	0.000373	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Prednisone—psoriasis	2.84e-05	0.000235	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—psoriasis	2.84e-05	0.000235	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—psoriasis	2.83e-05	0.000234	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—psoriasis	2.83e-05	0.000234	CcSEcCtD
Boceprevir—Anaemia—Prednisone—psoriasis	2.83e-05	0.000234	CcSEcCtD
Boceprevir—Shock—Betamethasone—psoriasis	2.82e-05	0.000233	CcSEcCtD
Boceprevir—Shock—Dexamethasone—psoriasis	2.82e-05	0.000233	CcSEcCtD
Boceprevir—Dyspnoea—Triamcinolone—psoriasis	2.82e-05	0.000233	CcSEcCtD
Boceprevir—Nervous system disorder—Dexamethasone—psoriasis	2.81e-05	0.000233	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—psoriasis	2.81e-05	0.000233	CcSEcCtD
Boceprevir—CTSL—Immune System—IFNG—psoriasis	2.81e-05	0.000368	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—psoriasis	2.81e-05	0.000368	CbGpPWpGaD
Boceprevir—Agitation—Prednisone—psoriasis	2.81e-05	0.000233	CcSEcCtD
Boceprevir—Thrombocytopenia—Betamethasone—psoriasis	2.81e-05	0.000232	CcSEcCtD
Boceprevir—Thrombocytopenia—Dexamethasone—psoriasis	2.81e-05	0.000232	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—psoriasis	2.8e-05	0.000232	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—psoriasis	2.8e-05	0.000232	CcSEcCtD
Boceprevir—Angioedema—Prednisone—psoriasis	2.79e-05	0.000231	CcSEcCtD
Boceprevir—Hypersensitivity—Cyclosporine—psoriasis	2.78e-05	0.00023	CcSEcCtD
Boceprevir—Dyspepsia—Triamcinolone—psoriasis	2.78e-05	0.00023	CcSEcCtD
Boceprevir—Erythema multiforme—Methotrexate—psoriasis	2.78e-05	0.00023	CcSEcCtD
Boceprevir—Nausea—Mycophenolic acid—psoriasis	2.77e-05	0.000229	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—psoriasis	2.77e-05	0.000229	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—psoriasis	2.77e-05	0.000229	CcSEcCtD
Boceprevir—Feeling abnormal—Hydrocortisone—psoriasis	2.76e-05	0.000229	CcSEcCtD
Boceprevir—Malaise—Prednisone—psoriasis	2.76e-05	0.000228	CcSEcCtD
Boceprevir—Vertigo—Prednisone—psoriasis	2.75e-05	0.000227	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—psoriasis	2.74e-05	0.000227	CcSEcCtD
Boceprevir—Gastrointestinal pain—Hydrocortisone—psoriasis	2.74e-05	0.000227	CcSEcCtD
Boceprevir—Syncope—Prednisone—psoriasis	2.74e-05	0.000227	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—psoriasis	2.74e-05	0.000359	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NFKB1—psoriasis	2.74e-05	0.000359	CbGpPWpGaD
Boceprevir—Tinnitus—Methotrexate—psoriasis	2.74e-05	0.000227	CcSEcCtD
Boceprevir—Urticaria—Prednisolone—psoriasis	2.73e-05	0.000226	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—psoriasis	2.72e-05	0.000226	CcSEcCtD
Boceprevir—Fatigue—Triamcinolone—psoriasis	2.72e-05	0.000225	CcSEcCtD
Boceprevir—CTSL—Immune System—CD4—psoriasis	2.71e-05	0.000356	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—psoriasis	2.71e-05	0.000356	CbGpPWpGaD
Boceprevir—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.71e-05	0.000225	CcSEcCtD
Boceprevir—Asthenia—Cyclosporine—psoriasis	2.71e-05	0.000224	CcSEcCtD
Boceprevir—Pain—Triamcinolone—psoriasis	2.7e-05	0.000224	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—psoriasis	2.69e-05	0.000222	CcSEcCtD
Boceprevir—Hypotension—Betamethasone—psoriasis	2.68e-05	0.000222	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—psoriasis	2.68e-05	0.000222	CcSEcCtD
Boceprevir—Pruritus—Cyclosporine—psoriasis	2.67e-05	0.000221	CcSEcCtD
Boceprevir—Urticaria—Hydrocortisone—psoriasis	2.66e-05	0.000221	CcSEcCtD
Boceprevir—Angiopathy—Methotrexate—psoriasis	2.66e-05	0.00022	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—psoriasis	2.66e-05	0.000349	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.66e-05	0.000348	CbGpPWpGaD
Boceprevir—Immune system disorder—Methotrexate—psoriasis	2.65e-05	0.000219	CcSEcCtD
Boceprevir—Body temperature increased—Hydrocortisone—psoriasis	2.65e-05	0.000219	CcSEcCtD
Boceprevir—Abdominal pain—Hydrocortisone—psoriasis	2.65e-05	0.000219	CcSEcCtD
Boceprevir—Mediastinal disorder—Methotrexate—psoriasis	2.65e-05	0.000219	CcSEcCtD
Boceprevir—Asthenia—Mycophenolate mofetil—psoriasis	2.64e-05	0.000219	CcSEcCtD
Boceprevir—Hypertension—Prednisone—psoriasis	2.64e-05	0.000219	CcSEcCtD
Boceprevir—Chills—Methotrexate—psoriasis	2.63e-05	0.000218	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—NFKB1—psoriasis	2.63e-05	0.000345	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRB1—psoriasis	2.63e-05	0.000344	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Betamethasone—psoriasis	2.61e-05	0.000216	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.61e-05	0.000216	CcSEcCtD
Boceprevir—Pruritus—Mycophenolate mofetil—psoriasis	2.6e-05	0.000216	CcSEcCtD
Boceprevir—Myalgia—Prednisone—psoriasis	2.6e-05	0.000215	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—psoriasis	2.6e-05	0.000215	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—psoriasis	2.6e-05	0.000215	CcSEcCtD
Boceprevir—Anxiety—Prednisone—psoriasis	2.59e-05	0.000215	CcSEcCtD
Boceprevir—Alopecia—Methotrexate—psoriasis	2.59e-05	0.000215	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—psoriasis	2.59e-05	0.000215	CcSEcCtD
Boceprevir—Insomnia—Betamethasone—psoriasis	2.59e-05	0.000215	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.59e-05	0.000214	CcSEcCtD
Boceprevir—Diarrhoea—Cyclosporine—psoriasis	2.58e-05	0.000214	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—psoriasis	2.57e-05	0.000213	CcSEcCtD
Boceprevir—Paraesthesia—Betamethasone—psoriasis	2.57e-05	0.000213	CcSEcCtD
Boceprevir—Discomfort—Prednisone—psoriasis	2.57e-05	0.000213	CcSEcCtD
Boceprevir—Mental disorder—Methotrexate—psoriasis	2.57e-05	0.000213	CcSEcCtD
Boceprevir—Malnutrition—Methotrexate—psoriasis	2.56e-05	0.000212	CcSEcCtD
Boceprevir—Erythema—Methotrexate—psoriasis	2.56e-05	0.000212	CcSEcCtD
Boceprevir—Hypersensitivity—Prednisolone—psoriasis	2.53e-05	0.000209	CcSEcCtD
Boceprevir—Dyspepsia—Dexamethasone—psoriasis	2.52e-05	0.000209	CcSEcCtD
Boceprevir—Dyspepsia—Betamethasone—psoriasis	2.52e-05	0.000209	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—IL6—psoriasis	2.52e-05	0.00033	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—psoriasis	2.52e-05	0.00033	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—psoriasis	2.52e-05	0.00033	CbGpPWpGaD
Boceprevir—Diarrhoea—Mycophenolate mofetil—psoriasis	2.52e-05	0.000209	CcSEcCtD
Boceprevir—Urticaria—Triamcinolone—psoriasis	2.51e-05	0.000208	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—psoriasis	2.5e-05	0.000207	CcSEcCtD
Boceprevir—CTSS—Immune System—NFKBIA—psoriasis	2.5e-05	0.000328	CbGpPWpGaD
Boceprevir—Body temperature increased—Triamcinolone—psoriasis	2.5e-05	0.000207	CcSEcCtD
Boceprevir—Dizziness—Cyclosporine—psoriasis	2.5e-05	0.000207	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—psoriasis	2.49e-05	0.000206	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—psoriasis	2.49e-05	0.000206	CcSEcCtD
Boceprevir—CTSK—Immune System—TYK2—psoriasis	2.49e-05	0.000326	CbGpPWpGaD
Boceprevir—Infection—Prednisone—psoriasis	2.48e-05	0.000205	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.48e-05	0.000325	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Betamethasone—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Dexamethasone—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Back pain—Methotrexate—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Hypersensitivity—Hydrocortisone—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—psoriasis	2.47e-05	0.000205	CcSEcCtD
Boceprevir—Shock—Prednisone—psoriasis	2.46e-05	0.000203	CcSEcCtD
Boceprevir—Pain—Betamethasone—psoriasis	2.45e-05	0.000203	CcSEcCtD
Boceprevir—Pain—Dexamethasone—psoriasis	2.45e-05	0.000203	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—psoriasis	2.45e-05	0.000203	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—psoriasis	2.44e-05	0.000202	CcSEcCtD
Boceprevir—Dizziness—Mycophenolate mofetil—psoriasis	2.43e-05	0.000202	CcSEcCtD
Boceprevir—CTSV—Immune System—JUN—psoriasis	2.43e-05	0.000318	CbGpPWpGaD
Boceprevir—CTSL—Immune System—JUN—psoriasis	2.43e-05	0.000318	CbGpPWpGaD
Boceprevir—Skin disorder—Prednisone—psoriasis	2.42e-05	0.000201	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—psoriasis	2.41e-05	0.0002	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—psoriasis	2.41e-05	0.000199	CcSEcCtD
Boceprevir—Asthenia—Hydrocortisone—psoriasis	2.41e-05	0.000199	CcSEcCtD
Boceprevir—Vomiting—Cyclosporine—psoriasis	2.4e-05	0.000199	CcSEcCtD
Boceprevir—Rash—Cyclosporine—psoriasis	2.38e-05	0.000197	CcSEcCtD
Boceprevir—Dermatitis—Cyclosporine—psoriasis	2.38e-05	0.000197	CcSEcCtD
Boceprevir—Pruritus—Hydrocortisone—psoriasis	2.37e-05	0.000196	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—psoriasis	2.37e-05	0.000196	CcSEcCtD
Boceprevir—Headache—Cyclosporine—psoriasis	2.36e-05	0.000196	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—LEP—psoriasis	2.36e-05	0.00031	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—psoriasis	2.36e-05	0.00031	CbGpPWpGaD
Boceprevir—Anaemia—Methotrexate—psoriasis	2.36e-05	0.000196	CcSEcCtD
Boceprevir—Feeling abnormal—Dexamethasone—psoriasis	2.36e-05	0.000195	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—psoriasis	2.36e-05	0.000195	CcSEcCtD
Boceprevir—Gastrointestinal pain—Betamethasone—psoriasis	2.34e-05	0.000194	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dexamethasone—psoriasis	2.34e-05	0.000194	CcSEcCtD
Boceprevir—Vomiting—Mycophenolate mofetil—psoriasis	2.34e-05	0.000194	CcSEcCtD
Boceprevir—CTSL—Immune System—NFKB1—psoriasis	2.34e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKB1—psoriasis	2.34e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—psoriasis	2.33e-05	0.000305	CbGpPWpGaD
Boceprevir—Hypersensitivity—Triamcinolone—psoriasis	2.33e-05	0.000193	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.32e-05	0.000304	CbGpPWpGaD
Boceprevir—Rash—Mycophenolate mofetil—psoriasis	2.32e-05	0.000192	CcSEcCtD
Boceprevir—Dermatitis—Mycophenolate mofetil—psoriasis	2.32e-05	0.000192	CcSEcCtD
Boceprevir—Headache—Mycophenolate mofetil—psoriasis	2.31e-05	0.000191	CcSEcCtD
Boceprevir—Malaise—Methotrexate—psoriasis	2.3e-05	0.000191	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—psoriasis	2.3e-05	0.00019	CcSEcCtD
Boceprevir—Diarrhoea—Hydrocortisone—psoriasis	2.29e-05	0.00019	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—psoriasis	2.29e-05	0.000189	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—NDUFA5—psoriasis	2.28e-05	0.000299	CbGpPWpGaD
Boceprevir—Urticaria—Dexamethasone—psoriasis	2.28e-05	0.000188	CcSEcCtD
Boceprevir—Urticaria—Betamethasone—psoriasis	2.28e-05	0.000188	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—psoriasis	2.27e-05	0.000188	CcSEcCtD
Boceprevir—Insomnia—Prednisone—psoriasis	2.26e-05	0.000187	CcSEcCtD
Boceprevir—CTSK—Immune System—CD4—psoriasis	2.25e-05	0.000295	CbGpPWpGaD
Boceprevir—Nausea—Cyclosporine—psoriasis	2.24e-05	0.000186	CcSEcCtD
Boceprevir—Paraesthesia—Prednisone—psoriasis	2.24e-05	0.000185	CcSEcCtD
Boceprevir—Pruritus—Triamcinolone—psoriasis	2.23e-05	0.000185	CcSEcCtD
Boceprevir—Cough—Methotrexate—psoriasis	2.23e-05	0.000185	CcSEcCtD
Boceprevir—Dizziness—Hydrocortisone—psoriasis	2.22e-05	0.000184	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NFKBIA—psoriasis	2.2e-05	0.000289	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—psoriasis	2.2e-05	0.000182	CcSEcCtD
Boceprevir—Nausea—Mycophenolate mofetil—psoriasis	2.19e-05	0.000181	CcSEcCtD
Boceprevir—Chest pain—Methotrexate—psoriasis	2.18e-05	0.00018	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—psoriasis	2.18e-05	0.00018	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—psoriasis	2.18e-05	0.00018	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—psoriasis	2.17e-05	0.00018	CcSEcCtD
Boceprevir—Rash—Prednisolone—psoriasis	2.17e-05	0.000179	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—psoriasis	2.16e-05	0.000179	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.16e-05	0.000179	CcSEcCtD
Boceprevir—Fatigue—Prednisone—psoriasis	2.15e-05	0.000178	CcSEcCtD
Boceprevir—Headache—Prednisolone—psoriasis	2.15e-05	0.000178	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—psoriasis	2.15e-05	0.000178	CcSEcCtD
Boceprevir—Constipation—Prednisone—psoriasis	2.13e-05	0.000177	CcSEcCtD
Boceprevir—Vomiting—Hydrocortisone—psoriasis	2.13e-05	0.000177	CcSEcCtD
Boceprevir—Rash—Hydrocortisone—psoriasis	2.11e-05	0.000175	CcSEcCtD
Boceprevir—Dermatitis—Hydrocortisone—psoriasis	2.11e-05	0.000175	CcSEcCtD
Boceprevir—Confusional state—Methotrexate—psoriasis	2.1e-05	0.000174	CcSEcCtD
Boceprevir—CTSV—Immune System—STAT3—psoriasis	2.1e-05	0.000276	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—psoriasis	2.1e-05	0.000276	CbGpPWpGaD
Boceprevir—Headache—Hydrocortisone—psoriasis	2.1e-05	0.000174	CcSEcCtD
Boceprevir—Dizziness—Triamcinolone—psoriasis	2.09e-05	0.000173	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IL6—psoriasis	2.09e-05	0.000274	CbGpPWpGaD
Boceprevir—Infection—Methotrexate—psoriasis	2.07e-05	0.000172	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisone—psoriasis	2.06e-05	0.00017	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—psoriasis	2.06e-05	0.00017	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—psoriasis	2.06e-05	0.00017	CcSEcCtD
Boceprevir—CTSS—Immune System—TYK2—psoriasis	2.05e-05	0.000268	CbGpPWpGaD
Boceprevir—Nervous system disorder—Methotrexate—psoriasis	2.05e-05	0.000169	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—psoriasis	2.04e-05	0.000169	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—psoriasis	2.04e-05	0.000169	CcSEcCtD
Boceprevir—Nausea—Prednisolone—psoriasis	2.04e-05	0.000169	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.04e-05	0.000267	CbGpPWpGaD
Boceprevir—Pruritus—Dexamethasone—psoriasis	2.03e-05	0.000168	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—psoriasis	2.03e-05	0.000168	CcSEcCtD
Boceprevir—Skin disorder—Methotrexate—psoriasis	2.03e-05	0.000168	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—psoriasis	2.02e-05	0.000167	CcSEcCtD
Boceprevir—CTSK—Immune System—JUN—psoriasis	2.01e-05	0.000264	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.01e-05	0.000264	CbGpPWpGaD
Boceprevir—Vomiting—Triamcinolone—psoriasis	2.01e-05	0.000166	CcSEcCtD
Boceprevir—Nausea—Hydrocortisone—psoriasis	1.99e-05	0.000165	CcSEcCtD
Boceprevir—Rash—Triamcinolone—psoriasis	1.99e-05	0.000165	CcSEcCtD
Boceprevir—Dermatitis—Triamcinolone—psoriasis	1.99e-05	0.000165	CcSEcCtD
Boceprevir—Urticaria—Prednisone—psoriasis	1.98e-05	0.000164	CcSEcCtD
Boceprevir—Headache—Triamcinolone—psoriasis	1.98e-05	0.000164	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—psoriasis	1.97e-05	0.000163	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—psoriasis	1.97e-05	0.000163	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—psoriasis	1.96e-05	0.000162	CcSEcCtD
Boceprevir—Diarrhoea—Betamethasone—psoriasis	1.96e-05	0.000162	CcSEcCtD
Boceprevir—Hypotension—Methotrexate—psoriasis	1.95e-05	0.000161	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—CYP2S1—psoriasis	1.94e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKB1—psoriasis	1.94e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—psoriasis	1.92e-05	0.000251	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Methotrexate—psoriasis	1.9e-05	0.000157	CcSEcCtD
Boceprevir—Dizziness—Betamethasone—psoriasis	1.89e-05	0.000157	CcSEcCtD
Boceprevir—Dizziness—Dexamethasone—psoriasis	1.89e-05	0.000157	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—psoriasis	1.89e-05	0.000156	CcSEcCtD
Boceprevir—Nausea—Triamcinolone—psoriasis	1.88e-05	0.000155	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—psoriasis	1.87e-05	0.000155	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—psoriasis	1.86e-05	0.000154	CcSEcCtD
Boceprevir—CTSS—Immune System—CD4—psoriasis	1.85e-05	0.000243	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—psoriasis	1.84e-05	0.000152	CcSEcCtD
Boceprevir—Dyspepsia—Methotrexate—psoriasis	1.84e-05	0.000152	CcSEcCtD
Boceprevir—Vomiting—Betamethasone—psoriasis	1.82e-05	0.000151	CcSEcCtD
Boceprevir—Vomiting—Dexamethasone—psoriasis	1.82e-05	0.000151	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—psoriasis	1.81e-05	0.00015	CcSEcCtD
Boceprevir—Rash—Dexamethasone—psoriasis	1.81e-05	0.00015	CcSEcCtD
Boceprevir—Rash—Betamethasone—psoriasis	1.81e-05	0.00015	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—psoriasis	1.81e-05	0.000149	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—psoriasis	1.81e-05	0.000149	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—TYK2—psoriasis	1.8e-05	0.000237	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Methotrexate—psoriasis	1.8e-05	0.000149	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—psoriasis	1.8e-05	0.000149	CcSEcCtD
Boceprevir—Headache—Dexamethasone—psoriasis	1.8e-05	0.000149	CcSEcCtD
Boceprevir—Headache—Betamethasone—psoriasis	1.8e-05	0.000149	CcSEcCtD
Boceprevir—Asthenia—Prednisone—psoriasis	1.79e-05	0.000148	CcSEcCtD
Boceprevir—Pain—Methotrexate—psoriasis	1.78e-05	0.000148	CcSEcCtD
Boceprevir—Pruritus—Prednisone—psoriasis	1.77e-05	0.000146	CcSEcCtD
Boceprevir—CTSK—Immune System—STAT3—psoriasis	1.74e-05	0.000228	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—psoriasis	1.72e-05	0.000226	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NDUFA5—psoriasis	1.72e-05	0.000226	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—psoriasis	1.72e-05	0.000225	CbGpPWpGaD
Boceprevir—Feeling abnormal—Methotrexate—psoriasis	1.72e-05	0.000142	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.71e-05	0.000225	CbGpPWpGaD
Boceprevir—Diarrhoea—Prednisone—psoriasis	1.71e-05	0.000141	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—psoriasis	1.71e-05	0.000141	CcSEcCtD
Boceprevir—Nausea—Dexamethasone—psoriasis	1.7e-05	0.000141	CcSEcCtD
Boceprevir—Nausea—Betamethasone—psoriasis	1.7e-05	0.000141	CcSEcCtD
Boceprevir—CTSS—Immune System—JUN—psoriasis	1.66e-05	0.000217	CbGpPWpGaD
Boceprevir—Urticaria—Methotrexate—psoriasis	1.66e-05	0.000137	CcSEcCtD
Boceprevir—Dizziness—Prednisone—psoriasis	1.65e-05	0.000137	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—psoriasis	1.65e-05	0.000136	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—psoriasis	1.65e-05	0.000136	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.6e-05	0.00021	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NFKB1—psoriasis	1.6e-05	0.000209	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—psoriasis	1.59e-05	0.000131	CcSEcCtD
Boceprevir—Rash—Prednisone—psoriasis	1.57e-05	0.00013	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—psoriasis	1.57e-05	0.00013	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCL8—psoriasis	1.57e-05	0.000206	CbGpPWpGaD
Boceprevir—Headache—Prednisone—psoriasis	1.56e-05	0.000129	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—psoriasis	1.54e-05	0.000127	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.53e-05	0.0002	CbGpPWpGaD
Boceprevir—Asthenia—Methotrexate—psoriasis	1.5e-05	0.000124	CcSEcCtD
Boceprevir—Nausea—Prednisone—psoriasis	1.48e-05	0.000123	CcSEcCtD
Boceprevir—Pruritus—Methotrexate—psoriasis	1.48e-05	0.000122	CcSEcCtD
Boceprevir—CTSV—Immune System—IL6—psoriasis	1.47e-05	0.000192	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—psoriasis	1.47e-05	0.000192	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2S1—psoriasis	1.46e-05	0.000192	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JUN—psoriasis	1.46e-05	0.000191	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—psoriasis	1.43e-05	0.000188	CbGpPWpGaD
Boceprevir—Diarrhoea—Methotrexate—psoriasis	1.43e-05	0.000118	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NFKB1—psoriasis	1.41e-05	0.000184	CbGpPWpGaD
Boceprevir—Dizziness—Methotrexate—psoriasis	1.38e-05	0.000114	CcSEcCtD
Boceprevir—Vomiting—Methotrexate—psoriasis	1.33e-05	0.00011	CcSEcCtD
Boceprevir—Rash—Methotrexate—psoriasis	1.31e-05	0.000109	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—psoriasis	1.31e-05	0.000109	CcSEcCtD
Boceprevir—Headache—Methotrexate—psoriasis	1.31e-05	0.000108	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—VEGFA—psoriasis	1.28e-05	0.000167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—psoriasis	1.26e-05	0.000166	CbGpPWpGaD
Boceprevir—Nausea—Methotrexate—psoriasis	1.24e-05	0.000103	CcSEcCtD
Boceprevir—CTSK—Immune System—IL6—psoriasis	1.22e-05	0.000159	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.14e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.09e-05	0.000143	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NDUFA5—psoriasis	1.06e-05	0.000139	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—psoriasis	1e-05	0.000131	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.92e-06	0.00013	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—psoriasis	9.64e-06	0.000126	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CARM1—psoriasis	9.48e-06	0.000124	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2S1—psoriasis	9.03e-06	0.000118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—psoriasis	8.82e-06	0.000116	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.5e-06	0.000112	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.5e-06	9.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CARM1—psoriasis	7.15e-06	9.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—psoriasis	5.83e-06	7.65e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—psoriasis	4.53e-06	5.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CARM1—psoriasis	4.41e-06	5.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—psoriasis	4.4e-06	5.77e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—psoriasis	3.95e-06	5.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—psoriasis	3.42e-06	4.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—psoriasis	2.98e-06	3.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—psoriasis	2.71e-06	3.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—psoriasis	2.11e-06	2.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—psoriasis	1.83e-06	2.41e-05	CbGpPWpGaD
